Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Considerations for Pharmacists Working in Major Disaster Areas

Author(s):  Kawataba Yoshinori

Issue:  Nov/Dec 2013 - Volume 17, Number 6
View All Articles in Issue

Page(s):  459-463

Considerations for Pharmacists Working in Major Disaster Areas Page 1
Considerations for Pharmacists Working in Major Disaster Areas Page 2
Considerations for Pharmacists Working in Major Disaster Areas Page 3
Considerations for Pharmacists Working in Major Disaster Areas Page 4
Considerations for Pharmacists Working in Major Disaster Areas Page 5

Download in electronic PDF format for $75

Abstract:  Japan experienced the Great East Japan Earthquake on March 11, 2011. Medical workers, including pharmacists, responded to the stricken areas to assist the affected patients with their medical needs. Although there are many published reports concerning the human suffering and medical problems resulting from this earthquake, very few of the published reports are by pharmacists documenting their experiences and perspective. It is important that pharmacists who respond to disasters document and report their experiences, as this information is vital for future responders. The authors, who were also responders of the Great East Japan Earthquake, evaluated the wasted drugs, compared the wasted drugs with the number of drugs prepared before dispatch to the affected areas, and documented the information that was gathered. A list of drugs, which was necessary to handle the subacute and chronic phases used at the stricken areas, was prepared and drug requirement tendencies investigated. The information gathered in this report may help pharmacists who are involved in similar situations in the future.

Related Keywords: natural disasters, earthquake, tsunami, Japan, drug supply, disaster preparedness

Related Categories: PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Considerations for Pharmacists Working in Major Disaster Areas
Kawataba Yoshinori
Nov/Dec 2013
Pg. 459-463

Natural Tragedies: Planning for Disasters and Emergencies
Williams LaVonn A
Sep/Oct 2011
Pg. 368-371

Insurance Considerations for the Pharmacy Professional
Jones Kirsten
May/Jun 2021
Pg. 190-195

PostScription: Natural Tragedies: Pharmacists are Integral Members of the Emergency Healthcare Team
Williams LaVonn A
Jul/Aug 2011
Pg. 350-351

Safety for Employees in the Compounding Work Area
Allen Loyd V Jr
Jan/Feb 2002
Pg. 60-61

The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

Contamination Control in Compounding Areas
Mulder Kyle
, Gonzales Ben A
Jul/Aug 2019
Pg. 271-278

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies
Allen Loyd V Jr
Nov/Dec 2006
Pg. 450-451

The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase
, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015
Pg. 377-380

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
Mar/Apr 2022
Pg. 100-109

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
Sep/Oct 2023
Pg. 358-360

Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B
, Wilkin Noel E, Holmes Erin R
Nov/Dec 2015
Pg. 514-520

Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls
Gonzalez Mark
May/Jun 2015
Pg. 205-211

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
DiMaggio Jennifer Lyn
, Reed-Kane Dana
Jul/Aug 2003
Pg. 258-263

Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
Sep/Oct 2022
Pg. 385-395

Return to Top